1. Home
  2. SOPH vs MGTX Comparison

SOPH vs MGTX Comparison

Compare SOPH & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOPH
  • MGTX
  • Stock Information
  • Founded
  • SOPH 2011
  • MGTX 2015
  • Country
  • SOPH Switzerland
  • MGTX United States
  • Employees
  • SOPH N/A
  • MGTX N/A
  • Industry
  • SOPH Biotechnology: Biological Products (No Diagnostic Substances)
  • MGTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SOPH Health Care
  • MGTX Health Care
  • Exchange
  • SOPH Nasdaq
  • MGTX Nasdaq
  • Market Cap
  • SOPH 309.2M
  • MGTX 282.3M
  • IPO Year
  • SOPH 2021
  • MGTX N/A
  • Fundamental
  • Price
  • SOPH $4.58
  • MGTX $4.42
  • Analyst Decision
  • SOPH Strong Buy
  • MGTX Strong Buy
  • Analyst Count
  • SOPH 3
  • MGTX 2
  • Target Price
  • SOPH $7.33
  • MGTX $26.00
  • AVG Volume (30 Days)
  • SOPH 60.6K
  • MGTX 218.3K
  • Earning Date
  • SOPH 08-06-2024
  • MGTX 08-08-2024
  • Dividend Yield
  • SOPH N/A
  • MGTX N/A
  • EPS Growth
  • SOPH N/A
  • MGTX N/A
  • EPS
  • SOPH N/A
  • MGTX N/A
  • Revenue
  • SOPH $64,184,000.00
  • MGTX $697,000.00
  • Revenue This Year
  • SOPH $28.97
  • MGTX N/A
  • Revenue Next Year
  • SOPH $28.39
  • MGTX $447.29
  • P/E Ratio
  • SOPH N/A
  • MGTX N/A
  • Revenue Growth
  • SOPH 26.68
  • MGTX N/A
  • 52 Week Low
  • SOPH $2.13
  • MGTX $3.49
  • 52 Week High
  • SOPH $7.37
  • MGTX $7.60
  • Technical
  • Relative Strength Index (RSI)
  • SOPH 45.34
  • MGTX 47.28
  • Support Level
  • SOPH $4.48
  • MGTX $4.55
  • Resistance Level
  • SOPH $4.81
  • MGTX $5.12
  • Average True Range (ATR)
  • SOPH 0.20
  • MGTX 0.26
  • MACD
  • SOPH 0.01
  • MGTX 0.08
  • Stochastic Oscillator
  • SOPH 54.52
  • MGTX 43.44

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

Share on Social Networks: